The Company reported total revenue of
'Entourage's first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024,' said
Corporate Highlights During and After the First Quarter of 2024
On
In Q1 2024, Entourage increased production capacity to nearly 2.2 million pre-rolls per month.
Commercial Highlights
Entourage continues demonstrating its market strength and consumer appeal with a 10% year-over-year increase in adult-use revenue. This impressive growth reflects the Company's strategic initiatives and ability to adapt to the evolving market landscape.
In Q1 2024, the Dime Bag brand in
In Q1 2024, 80% of stores in
In Q1 2024, Entourage's national pre-roll market share was 2%. Color Cannabis also ranked 12th highest pre-roll brand in national dollar sales. It secured the number 2 spot in the pre-roll category in
The Company launched 11 new adult-use SKUs in Q1 2024, enhancing its product lineup across key markets. These SKUs included Color Cannabis 'Pedro's Sweet Sativa' and 'Blueberry Seagal Live Resin Infused' pre-rolls in
Additionally, Saturday unveiled 'Passionfruit Lavender' and 'Beached Mango' in 1 g 510 vape carts in
Starseed consistently broadens its product portfolio available to medical cannabis patients. This portfolio includes the introduction of new strains, advanced delivery methods, and specialized formulations, all designed to meet the diverse needs of the medical cannabis community.
About
Contact:
Tel: 416-910-0279
Email: catherine.flaman@entouragecorp.com
Forward Looking Information
This press release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation which are based upon Entourage's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified using forward-looking terminology such as 'expect', 'likely', 'may', 'will', 'should', 'intend', 'anticipate', 'potential', 'proposed', 'estimate' and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions 'may', 'would' or 'will' happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions, and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Entourage does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Entourage to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in Entourage's disclosure documents filed with the applicable Canadian securities' regulatory authorities on SEDAR+ at www.sedarplus.ca The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
(C) 2024 Electronic News Publishing, source